Dividend27 Apr 2026, 09:30 pm
Jagsonpal Board Recommends ₹4/Share Dividend for FY26
AI Summary
The Board of Directors of Jagsonpal Pharmaceuticals Ltd. has recommended a dividend of ₹4/- per equity share for the financial year ended March 31, 2026. This represents 200% of the face value of ₹2/- per share. The proposed dividend is contingent upon approval by the shareholders at the company's 47th Annual General Meeting. The specific record date and the tentative date for dividend payment will be communicated separately by the company.
Key Highlights
- Board recommended ₹4/share dividend for FY26.
- This represents 200% of the ₹2 face value.
- Dividend is subject to shareholder approval at 47th AGM.
- Record and payment dates to be announced later.
Price Impact
More from JAGSNPHARM